Phathom Pharmaceuticals, Inc. (PHAT) stock
PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.50−0.38 (-6.46%)
Close on Nov 17, 2026Market cap $447.10MP/E –Yield –
Phathom Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Phathom Pharmaceuticals's market cap was $502.84M on Nov 11, 2026, against $1.11B a year earlier. Over the last 5 years it ranged from $273.53M to $1.18B, with a median of $554.79M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $502.84M | -57.3% |
| 2025 | Dec 31, 2025 | $1.18B | +112.4% |
| 2024 | Dec 31, 2024 | $554.79M | +7.0% |
| 2023 | Dec 29, 2023 | $518.67M | +12.4% |
| 2022 | Dec 30, 2022 | $461.63M | -21.9% |
| 2021 | Dec 31, 2021 | $591.03M | -31.3% |
| 2020 | Dec 31, 2020 | $860.93M | +272.6% |
| 2019 | Dec 31, 2019 | $231.09M | – |
See a number that looks wrong?